Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.addr.2021.01.001 http://scihub22266oqcxt.onion/10.1016/j.addr.2021.01.001 33421475!7788321!33421475     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Adv+Drug+Deliv+Rev 2021 ; 170 (ä): 71-82 Nephropedia Template TP {{tp|p=33421475|t=2021. Recombinant protein vaccines, a proven approach against coronavirus pandemics |pdf=|usr=}}{{33421475}} gab.com Text Recombinant protein vaccines, a proven approach against coronavirus pandemics JO: Adv Drug Deliv Rev http://www.kidney.de/pget.php?&tw=1&pmid=33421475 #FOAvip With the COVID-19 pandemic now ongoing for close to a year, people all over the world are still waiting for a vaccine to become available. The initial focus of accelerated global research and development efforts to bring a vaccine to market as soon as possible was on novel platform technologies that promised speed but had limited history in the clinic. In contrast, recombinant protein vaccines, with numerous examples in the clinic for many years, missed out on the early wave of investments from government and industry. Emerging data are now surfacing suggesting that recombinant protein vaccines indeed might offer an advantage or complement to the nucleic acid or viral vector vaccines that will likely reach the clinic faster. Here, we summarize the current public information on the nature and on the development status of recombinant subunit antigens and adjuvants targeting SARS-CoV-2 infections. Twit Text FOAVip Recombinant protein vaccines, a proven approach against coronavirus pandemics ????Adv Drug Deliv Rev http://www.kidney.de/pget.php?&tw=1&pmid=33421475 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33421475 #FOAvip English Wikipedia <ref>{{Cite pmid|33421475}}</ref> Recombinant protein vaccines, a proven approach against coronavirus pandemics #MMPMID33421475 Pollet J; Chen WH; Strych U Adv Drug Deliv Rev 2021[Mar]; 170 (ä): 71-82 PMID33421475show ga With the COVID-19 pandemic now ongoing for close to a year, people all over the world are still waiting for a vaccine to become available. The initial focus of accelerated global research and development efforts to bring a vaccine to market as soon as possible was on novel platform technologies that promised speed but had limited history in the clinic. In contrast, recombinant protein vaccines, with numerous examples in the clinic for many years, missed out on the early wave of investments from government and industry. Emerging data are now surfacing suggesting that recombinant protein vaccines indeed might offer an advantage or complement to the nucleic acid or viral vector vaccines that will likely reach the clinic faster. Here, we summarize the current public information on the nature and on the development status of recombinant subunit antigens and adjuvants targeting SARS-CoV-2 infections. |Animals[MESH] |COVID-19 Vaccines/*administration & dosage/immunology[MESH] |COVID-19/epidemiology/immunology/*prevention & control[MESH] |Clinical Trials as Topic/methods[MESH] |Coronavirus Infections/epidemiology/immunology/prevention & control[MESH] |Drug Development/*methods[MESH] |Health Resources/trends[MESH] |Humans[MESH] |Pandemics/*prevention & control[MESH] |Recombinant Proteins/administration & dosage/immunology[MESH] |SARS-CoV-2/drug effects/immunology[MESH] |Vaccines, Synthetic/administration & dosage/immunology[MESH]Recombinant protein vaccines, a proven approach against coronavirus pa(epmc).pdf DeepDyve Pubget Overpricing